9/23/2026
Psyence BioMed announces ibogaine investment and trial plans
Psyence BioMed to invest $5M in PsyLabs, plans Texas ibogaine trial.
Topic archive
investment
4 stories
9/23/2026
Psyence Biomed announces ibogaine investment
The company aims to advance ibogaine research for mental health.
9/23/2026
Psyence Biomedical expands with Texas ibogaine unit
Company invests $5 million in PsyLabs for ibogaine research and production.
7/19/2026
Psychedelic drugs market sees positive growth signal
Investment interest grows in psychedelics for mental health treatment.